Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers
NCT04428593
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DRUG:
Treamid 5 mg
DRUG:
Treamid 15 mg
DRUG:
Treamid 50 mg
DRUG:
Placebo
Sponsor
PHARMENTERPRISES LLC